HSP90B1 and breast cancer: Intracellular and extracellular gp96 is closely associated with cancer aggressiveness (10, 11) and drug resistance (12), but the molecular mechanisms by which gp96 controls cancer progression and paclitaxel-resistance in BC have not been investigated.